Oral Eplerenone Versus Observation in the Management of Acute Central Serous Chorioretinopathy: A Prospective, Randomized Comparative Study
In this prospective, interventional case-control study, 58 patients with unilateral acute central serous chorioretinopathy (CSCR) were recruited. Patients ≥ 18 years age, presenting with first episodes of acute CSCR, were included. Acute CSCR was defined by the presence of subretinal fluid (SRF) and...
Saved in:
Main Authors: | Ramesh Venkatesh (Author), Arpitha Pereira (Author), Chaitra Jayadev (Author), Vishma Prabhu (Author), Aditya Aseem (Author), Kushagra Jain (Author), Bharathi Bavaharan (Author), Naresh Kumar Yadav (Author), Jay Chhablani (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
by: Katrin Fasler, et al.
Published: (2021) -
Central Serous Chorioretinopathy Classification
by: Manuel Vilela, et al.
Published: (2020) -
Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review
by: Francesco Sartini, et al.
Published: (2020) -
Central Serous Chorioretinopathy: Treatment with Laser
by: Maurizio Battaglia Parodi, et al.
Published: (2020) -
Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in-vitro optimization and ex-vivo assessment
by: Eman Abdelhakeem, et al.
Published: (2021)